2004•TumoriRequires access

The effects of Helicobacter pylori infection and cyclooxygenase-2 expression during the gastric carcinogenesis

Yun-liang Sun

Open publisher page 0 citations

Abstract

Objective To clarify the role of Helicobacter pylori (H. Pylori) that induced cyclooxygenase (COX)-2 expression during the gestric carcinogenesis. Methods A total of 138 gastric biopsies, including 30 cases with chronic non-atrophic gastritis, 85 cases with chronic atrophic gastritis (accompanying moderate or severe intestinal metaplasia 45 cases and dysplasia 12 cases), and 23 cases with gastric carcinoma were studied. H. pylori infection was assessed by rapid urease test and histological examination (modified Giemsa staining). Expression of COX-1 and COX-2 was detected by immunohistochemical stain. Results H. pylori infection rate was 69.6% in gastric carcinoma, significantly higher than 36.7% in chronic non-atrophic gastritis (P0.05). The positive expression rates of COX-2 were 10.0%, 37.6%, 37.8%, 41.7% and 69.6% in chronic non-atrophic gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia and gastric carcinoma respectively. From chronic non-atrophic gastritis to chronic atrophic gastritis to intestinal metaplasia to dysplasia to gastric carcinoma, expression of COX-2 showed as ascending tendency, whereas COX-1 expression did not change significantly in the gastric mucosa. COX-2 expression in chronic atrophic gastritis, intestinal metaplasia and dysplasia were significantly higher in H. pylori-positive than in H. pylori-negative subjects (P0.01). Conclusion COX-2 expression induced by H. pylori infection is a relatively early event during carcinogenesis in the stomach.

About this research paper

What this paper is about

Objective To clarify the role of Helicobacter pylori (H. Pylori) that induced cyclooxygenase (COX)-2 expression during the gestric carcinogenesis. Methods A total of 138 gastric biopsies, including 30 cases with chronic non-atrophic gastritis, 85 cases with chronic atrophic gastritis (accompanying moderate or severe intestinal metaplasia 45 cases and dysplasia 12 cases), and 23 cases with gastric carcinoma were studied. H. pylori infection was assessed by rapid urease test and histological examination (modified Giemsa staining). Expression of COX-1 and COX-2 was detected by immunohistochemical stain. Results H. pylori infection rate was 69.6% in gastric carcinoma, significantly higher than 36.7% in chronic non-atrophic gastritis (P0.05). The positive expression rates of COX-2 were 10.0%, 37.6%, 37.8%, 41.7% and 69.6% in chronic non-atrophic gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia and gastric carcinoma respectively. From chronic non-atrophic gastritis to chronic atrophic gastritis to intestinal metaplasia to dysplasia to gastric carcinoma, expression of COX-2 showed as ascending tendency, whereas COX-1 expression did not change significantly in the gastric mucosa. COX-2 expression in chronic atrophic gastritis, intestinal metaplasia and dysplasia were significantly higher in H. pylori-positive than in H. pylori-negative subjects (P0.01). Conclusion COX-2 expression induced by H. pylori infection is a relatively early event during carcinogenesis in the stomach.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To clarify the role of Helicobacter pylori (H. Pylori) that induced cyclooxygenase (COX)-2 expression during the gestric carcinogenesis. Methods A total of 138 gastric biopsies, including 30 cases with chronic non-atrophic gastritis, 85 cases with chronic atrophic gastritis (accompanying moderate or severe intestinal metaplasia 45 cases and dysplasia 12 cases), and 23 cases with gastric carcinoma were studied. H. pylori infection was assessed by rapid urease test and histological examination (modified Giemsa staining). Expression of COX-1 and COX-2 was detected by immunohistochemical stain. Results H. pylori infection rate was 69.6% in gastric carcinoma, significantly higher than 36.7% in chronic non-atrophic gastritis (P0.05). The positive expression rates of COX-2 were 10.0%, 37.6%, 37.8%, 41.7% and 69.6% in chronic non-atrophic gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia and gastric carcinoma respectively. From chronic non-atrophic gastritis to chronic atrophic gastritis to intestinal metaplasia to dysplasia to gastric carcinoma, expression of COX-2 showed as ascending tendency, whereas COX-1 expression did not change significantly in the gastric mucosa. COX-2 expression in chronic atrophic gastritis, intestinal metaplasia and dysplasia were significantly higher in H. pylori-positive than in H. pylori-negative subjects (P0.01). Conclusion COX-2 expression induced by H. pylori infection is a relatively early event during carcinogenesis in the stomach.

Key concepts: Atrophic gastritis, Intestinal metaplasia, Dysplasia, Helicobacter pylori, Medicine, Gastroenterology, Chronic gastritis, Gastritis

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects of Helicobacter pylori infection and cyclooxygenase-2 expression during the gastric carcinogenesis — Research Paper | ScholarLens